ENTA · Enanta Pharmaceuticals Inc · Congressional Trades
$11.55
-0.63 (-5.17%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2024 earnings call transcript
Market Cap
$354.75M
Shares
29.13M
Volume · Oct 28
282.01K
Avg daily vol (3M)
245.01K
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2023-07-12 | Daniel Goldman | Representative | Sell ST · Enanta Pharmaceuticals, Inc. (ENTA) | — Daniel Goldman Grandchildren 1986 Trust > TACS R3K | $1K - $15K | 2023-08-13 | 32d |
Showing 1–1 of 1 trades
Key facts
CIK
1177648
CUSIP
29251M106
13F (30d)
15 filings
15 filers
Visit website
Investor relations